Oral Abstract Presentations

Oral Presenters should also review the Speaker Information page. 

Concurrent Sessions

You will have a total of 12 minutes; 7 minutes of presentation, followed by 5 minutes for discussion.  Time limits will be strictly enforced.  Please be in the room for your session 10 minutes before the start time.  The chairpersons will start strictly on time and end on time.  Presentations times will not be changed.

We recommend that the background material be covered in 1-2 slides only.  All presenters are required to include a statement disclosing any conflict of interest related to your abstract as the first slide of your presentation.


Plenary Sessions

You will have a total of 10 minutes for your presentation followed by 5 minutes for discussion.  Time limits will be strictly enforced.  Please be in the room for your session 10 minutes before the start time.  The chairpersons will start strictly on time and end on time.  

We recommned that the background material be covered in 1-2 slides only.  All presenters are required to include a statement disclosing any conflict of interest related to your abstracts as the first slide of your presentation.


Speaker Disclosure Slide

All presenters are required to include the Speaker Disclosure Slide in their presentations. If you do not include this in your presentation prior to arriving onsite, you will be required to insert it in the speaker ready room. 

Generic and Trade Names

Presentations must give a balanced view of therapeutic options.
Faculty will be asked to use generic names to contribute to this impartiality.
If trade names are used, those of several companies should be used rather than only that of a single supporting company.

Unlabeled Uses of Products

When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during an educational activity the speaker should disclose that the product is not labeled for the use under discussion or that the product is still investigational.